News & Press Releases

All
  • All
  • Blog
  • Bowel Cancer
  • Case Study
  • Chemotoxicity
  • Colorectal Cancer
  • News
  • Personalised Medicine
  • Press Release

Oxford Cancer Biomarkers announces new investment to commercialise its colorectal cancer diagnostic tests

Oxford Cancer Biomarkers announces UK patent filed

Oxford Cancer Biomarkers announces the EU patent for the use of the biomarker HR23B

Oxford Cancer Biomarkers announces funding has been awarded for a pilot study of the ColoTox test

Oxford Cancer Biomarkers announces biomarker discovery and development deal with Daiichi-Sankyo

Oxford Cancer Biomarkers announces issued United States patent

Oxford Cancer Biomarkers announces biomarker discovery deal with AstraZeneca

Oxford Cancer Biomarkers appoints David Oxlade as its Chairman

Oxford Cancer Biomarkers appoints Nick McCooke as its CEO

Quintiles Forms New Biomarker Research and Development Company